Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Feb 16;110(1):179–188. doi: 10.1002/cpt.2161

Figure 3. Annual prevalence of exposure to A) statins, B) anticoagulants, and C) antiplatelets.

Figure 3.

A) Top line represents all statins with exposure to individual statins shown in the lines below. Exposure to any statin increased over time, whereas exposure to simvastatin decreased and exposure to atorvastatin increased. B) Top line represents all oral anticoagulants with exposure to individual anticoagulants shown in the lines below. Exposure to warfarin decreased over time; however, warfarin remained the most commonly prescribed anticoagulant. C) Top line represents all oral antiplatelet P2Y12 inhibitors with exposure to individual agents illustrated with the lines below. Exposure to clopidogrel remained higher than for other agents. Note that confidence intervals are represented by gray shading but may be too narrow to be observed.